The existence of radiosensitive subpopulations would have profound implications for assessing risks from medical, occupational and accidental exposures to ionizing radiation. Individuals with the heritable syndrome ataxia-telangiectasia (AT) have two defective copies of the ATM (Ataxia-Telangiectasia, Mutated) gene and are highly radiosensitive and cancer prone, but AT is rare and clinically detectable. AT heterozygotes, individuals with a single defective copy of the ATM gene, are clinically normal and make up about 1% of the population (Swift et al., 1986) . The suggestion that AT heterozygotes are predisposed to radiation-induced breast cancer, possibly even at exposures used for diagnostic purposes, is controversial (Boice and Miller, 1992; Bridges and Arlett, 1992; Hall et al., 1992; Kuller and Modan, 1992; Land, 1992; Swift et al., 1991; Wagner, 1992) . The design of molecular epidemiological studies to determine their cancer risk from radiation exposure is complicated by the large size of the gene, the many polymorphisms and mutations reported in it, and the diculty of accurately assessing radiation exposure. Here, we investigate the question of AT heterozygote susceptibility to radiogenic breast cancer using a murine model. We show that mammary epithelial cells from irradiated mice with one defective copy of the murine ATM homologue, Atm, are susceptible to radiationinduced genomic instability and can generate dysplastic mammary ducts when transplanted into syngenic recipients.
The mice used in this study had an engineered Atm mutation that interrupts the gene in the PI-3 kinase domain, a region that is truncated in some ataxiatelangiectasia patients (Barlow et al., 1996) . Mice homozygous for this Atm mutant allele or a similar one created in a dierent laboratory (Elson et al., 1996) have many of the same impairments found in ataxia-telangiectasia patients. Atm heterozygous mice (Atm +/7 ), like their human counterparts, appear to be normal. These mice have been followed after exposure to a sublethal dose of ionizing radiation but no signi®cant dierences in tumor incidence or spectrum were detected (Barlow et al., 1999) . The small numbers of mice studied and the radiation dose chosen, however, made the detection of susceptibility to radiogenic mammary tumors unlikely. We set out to determine if Atm heterozygosity increases susceptibility to radiation-induced mammary tumorigenesis using model systems in which its eects might be more evident.
First we assayed the level of Atm protein in Atm heterozygous mice as compared to mice with two normal copies of the gene and found that it is reduced by half in primary cultures of kidney and mammary epithelial cells (Figure 1 ) (Barlow et al., 1996) were obtained from the Jackson Laboratory (Bar Harbor, ME, USA) and maintained by breeding with 129S6/SvEvTac (129S6) mice from Taconics (Germantown, NY, USA). (a) Immunoblot of primary kidney epithelial cells from three Atm +/7 and three wild type mice. Immunoblotting was performed as described by Song et al. (1996) using a monoclonal anti-ATM antibody (ATM-2C1, Genetex). The signal intensities for each sample were normalized to those of Ku-70 detected on the same blot with a monoclonal anti-Ku-70 antibody (Clone N3H10, NeoMarkers and Atm wild type (wt) mice. Mammary cell donors were F1 hybrids from matings of 129S6-Atm +/7 and C57BL/6J. Recipients were progeny from 129S6 x C57BL/6J matings. Mammary epithelial cells from irradiated donor mice were transplanted to cleared mammary fat pads of recipient mice as previously described (Ullrich et al., 1996) . Results are from three experiments with paired littermates yielding 75 outgrowths from Atm +/7 mice and 78 outgrowths from Atm wild type mice. Mammary epithelial cells from all of the Atm +/7 mice tested generated dysplastic ducts (Fisher's exact test, P=0.00142). (b and c) Whole mounts of (b) dysplastic and (c) normal mammary gland outgrowths. (d) Hematoxylin and eosin stained histological section of the outgrowth shown in b. *As above these cells were scored for chomatid aberrations (Figure 2 ). Since chromatid aberrations are converted to chromosome type aberrations in mitosis and are therefore not transmitted through subsequent rounds of cell division, they are indicative of ongoing instability in the progeny of irradiated cells. Without prior irradiation, metaphase mammary epithelial cells from both Atm heterozygous and Atm wild type mice had about 0.04 chromatid aberrations per cell. The number of chromatid aberrations was 0.05 per cell in cells from irradiated mice with two normal copies of Atm, but approximately 0.12 per cell in cells from irradiated Atm +/7 mice. We next tested the potential of irradiated mammary epithelial cells from Atm +/7 mice to generate ductal dysplasias in an outgrowth assay. Previous studies have demonstrated that radiation-induced ductal dysplasias, which are precursors to mammary cancer, are derived from radiation-initiated cells (Adams et al., 1987) . As such they are a rapid and sensitive quantitative measure of susceptibility to radiation-induced mammary cancer (Ullrich et al., 1996) . Mammary epithelial cells were harvested from mice irradiated with 1 Gy 6 weeks previously. Aliquots containing only a few clonogenic cells were transplanted into the mammary fat pads of multiple, 3-week-old 129S6B6F1 recipients from which the rudimentary mammary tissue had been removed. Ten weeks later mammary outgrowths from the transplanted mammary epithelial cells were examined for ductal dysplasia. About 10% (0.108+0.005) of outgrowths derived from cells donated by irradiated Atm heterozygous mice contained dysplastic ducts, whereas cells from irradiated Atm wild type mice formed only normal ducts (Figure 3 ). Twenty-four outgrowths generated from mammary epithelial cells harvested from unirradiated Atm heterozygous mice had normal ducts. This small number suggests but does not prove that exposure to ionizing radiation is necessary for ductal dysplasia in this system.
The susceptibility of mammary epithelial cells from Atm heterozygous mice to radiation-induced genomic instability and ductal dysplasia points to Atm heterozygosity as a risk factor for radiation-induced breast cancer, at least in mice. Extrapolation of these data to humans is confounded by many factors in addition to the species dierence, including age at time of irradiation and the distribution of dose over time. It should be noted, however, that current radiotherapy protocols for breast cancer deliver 2 to 3 Gy over 6 weeks to the inner quadrant of the unaected contralateral breast, decreasing fourfold (or more) across the breast. While current exposure standards call for a dose of less than 8 mGy for a two-view per breast mammographic examination, prior to a decade ago many women were exposed to doses greater than 0.1 Gy (Bicehouse, 1975; Conway et al., 1994; Upton et al., 1977) .
